Navigation Links
Researchers describe a new genetic program that converts static cells into mobile invasive cells
Date:12/15/2011

Researchers at the Institute for Research in Biomedicine (IRB Barcelona) have identified the gene GATA 6 as responsible for epithelial cells -which group together and are static- losing adhesion and moving towards a new site. This process, which is common to developing organisms, is very similar to one that occurs in metastasis, when tumour cells escape from the original tumour and invade new tissue. "This process explains why Gata 6 is found in cancers of the liver, pancreas and colon, thus allowing tumour cells to acquire metastatic properties", stresses Jordi Casanova, CSIC professor and head of the Drosophila Morphogenesis Group at IRB Barcelona, where the study has been conducted. The journal Developmental Cell is to publish the results of this study this week.

In addition, Gata 6 triggers a genetic programme that favours the survival and adaptation of cells in new tissue. It also promotes the expression of some enzymes, the so-called metalloproteases, which degrade the cellular matrix, thus allowing cells to migrate and enter new tissue. Furthermore, Gata 6 induces the gene Forkhead, which is a survival factor. "When cells start migrating they are subjected to many changes and to stress, and in these adverse conditions many can die. This gene protects them against death", explains Kira Campbell, "Juan de la Cierva" post-doctoral fellow with Casanova's lab and first author of the article. Tumour cells hold metalloproteases and Forkhead.

From the Drosophila fly to cancer

Once again the small fly D. melanogaster, used in developmental studies, has shed light on processes linked to cancer. Casanova's team, which specializes in morphogenesis, has revealed the mechanism by which epithelial cells transform into mesenchymatic cells during gut development in fly embryos. The Drosophila gut is an endodermal organ, as is the colon, the liver and the pancreas. "What we have discovered is that the programme that we have characterized for the first time is specific for endodermal tissues", explains Casanova.

Having identified the genetic programme that favours this transformation in Drosophila, Casanova contacted Eduard Batlle's lab, which focuses on colorectal cancer and is also at IRB Barcelona. The aim was to test whether the homologue gene in mammal cells had the capacity to produce this same change. Their studies showed that this gene homologue, GATA 6, is conserved and confers cells the same capacities as those observed in the fly. "We started off with a strictly basic research line in development and have ended up with a collaboration with the Oncology Programme to address possible implications in cancer", says Casanova, emphasizing the multidisciplinary nature of the study. His lab now wishes to turn its attention to other members of the GATA family. "For example, pancreatic cancer has very poor prognosis. Our research can contribute to furthering understanding of the genetic bases of endodermal tumours and may speed up the detection of possible therapeutic targets".


'/>"/>
Contact: Snia Armengou
sonia.armengou@irbbarcelona.org
34-934-037-255
Institute for Research in Biomedicine (IRB Barcelona)
Source:Eurekalert  

Related medicine news :

1. UIC researchers discover how cells limit inflammation in lung injury
2. Researchers identify phthalates in numeruous medicines and supplements
3. BUSM researchers find link between pulmonary inflammation, diesel exhaust, house dust
4. Jefferson researchers mirror human response to bacterial infection and resolution in mice
5. Leibniz Prize 2012 to honor 11 outstanding researchers
6. Moffitt Cancer Center researchers find potential target for treating metastatic cancer
7. A good nose: RUB-Researchers decipher interaction of fragrances and olfactory receptors
8. Nanoparticles help researchers deliver steroids to retina
9. Researchers develop conversation cards to broach subject of pediatric weight management
10. Researchers identify agent responsible for protection against early stages of atherosclerosis
11. Researchers use new finding to clear bloodstream malaria infection in mice
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Researchers describe a new genetic program that converts static cells into mobile invasive cells
(Date:7/24/2017)... ... 2017 , ... SignatureCare Emergency Center is looking to award their ... to a deserving student. Get your applications in now as the deadline is ... Castillo who is a nursing student at Prairie View A&M University with a 3.45 ...
(Date:7/24/2017)... , ... July 24, 2017 , ... ... Oakland, California effectively destroyed the construction site and threatened numerous homes and businesses ... 7th article on NBCLosAngeles.com. Los Angeles Area consulting firm Fire Protection ...
(Date:7/24/2017)... CLARA, CA (PRWEB) , ... July 24, 2017 , ... ... and financial organizations, today announced it has partnered with WALLIX to expand ... Special Publication 800-171 . , There are a number of ways to address the ...
(Date:7/24/2017)... California (PRWEB) , ... July 24, 2017 , ... ... of autologous fat (adipose) transfer systems announces the issuance of United States Patent ... patent) for its adipose filtration technology. The '398 and '324 patents cover ...
(Date:7/24/2017)... , ... July 24, 2017 , ... ... sleep management solution focused on delivering end-to-end sleep health care at scale, ... Recent literature shows that adherence rates for positive airway pressure (PAP) therapy, the ...
Breaking Medicine News(10 mins):
(Date:7/21/2017)... and EDMONTON, Alberta , July ... and the University of Alberta in ... in Nature,s partner journal, Schizophrenia 1 , demonstrating ... instances of schizophrenia with 74% accuracy. This retrospective ... of specific symptoms in schizophrenia patients with significant ...
(Date:7/21/2017)... , July 21, 2017  Endo International plc (NASDAQ: ... a comprehensive review of its manufacturing network, the Company ... distribution facilities in Huntsville, Alabama . ... place over the next 12 to 18 months. The ... by declining volumes of commoditized products and these restructuring ...
(Date:7/20/2017)... , July 20, 2017  Prime Therapeutics LLC (Prime) ... Gavras , M.D., following today,s Institute for Clinical and Economic ... on the effectiveness and value of abuse-deterrent formulations (ADF) ... the policy roundtable at the meeting. ... a material cost benefit to the use of abuse-deterrent formulations ...
Breaking Medicine Technology: